This list is an analysis based on recent market events. It's not an investment recommendation.
About
UnicoCell Biomed Co., Ltd. engages in the research and development of stem cell drugs in Taiwan and Japan. The company develops ELIXCYTE for the treatment of knee osteoarthritis and chronic kidney disease. It also operates an allogeneic adipose stem cell bank. In addition, the company offers autologous stem cell therapy; conditioned medium; UnicoVial, a cryogenic vial for the storage of cell products and biological samples under ultra-low temperature; and laboratory testing services, which include sterility, endotoxin, mycoplasma, and cell count and viability tests, as well as contract development and manufacturing organization (CDMO) services for cell-based products. UnicoCell Biomed Co., Ltd. was founded in 2011 and is based in Taipei, Taiwan.
The current price of 6794.TW is TWD80.5 TWD — it has decreased by -0.25% in the past 24 hours. Watch UnicoCell Biomed stock price performance more closely on the chart.
What is UnicoCell Biomed stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange UnicoCell Biomed stocks are traded under the ticker 6794.TW.
What is UnicoCell Biomed market cap?▼
Today UnicoCell Biomed has the market capitalization of 5.12B
When is the next UnicoCell Biomed earnings date?▼
UnicoCell Biomed is going to release the next earnings report on May 07, 2026.
What is UnicoCell Biomed revenue for the last year?▼
UnicoCell Biomed revenue for the last year amounts to 60.21M TWD.
What is UnicoCell Biomed net income for the last year?▼
6794.TW net income for the last year is -229.67M TWD.
In which sector is UnicoCell Biomed located?▼
UnicoCell Biomed operates in the Other sector.
When did UnicoCell Biomed complete a stock split?▼
UnicoCell Biomed has not had any recent stock splits.
Where is UnicoCell Biomed headquartered?▼
UnicoCell Biomed is headquartered in Taipei, Taiwan.